
John D. Ulm
Examiner (ID: 10769, Phone: (571)272-0880 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1812, 1646, 1805 |
| Total Applications | 2240 |
| Issued Applications | 1195 |
| Pending Applications | 205 |
| Abandoned Applications | 843 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11873617
[patent_doc_number] => 09745373
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'Anti-CGRP compositions and use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/476465
[patent_app_country] => US
[patent_app_date] => 2012-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 76
[patent_no_of_words] => 50669
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13476465
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/476465 | Anti-CGRP compositions and use thereof | May 20, 2012 | Issued |
Array
(
[id] => 9491044
[patent_doc_number] => 20140141451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'ASSAY TO DETERMINE LRRK2 ACTIVITY IN PARKINSON\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/118547
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 22905
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118547
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/118547 | Assay to determine LRRK2 activity in parkinson's disease | May 17, 2012 | Issued |
Array
(
[id] => 10156023
[patent_doc_number] => 09187784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-17
[patent_title] => 'EphA4 is a disease modifier in motor neuron disease'
[patent_app_type] => utility
[patent_app_number] => 14/117591
[patent_app_country] => US
[patent_app_date] => 2012-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14754
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117591
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/117591 | EphA4 is a disease modifier in motor neuron disease | May 13, 2012 | Issued |
Array
(
[id] => 8489040
[patent_doc_number] => 20120288447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'PEPTIDE WHICH PASSES THROUGH BLOOD-BRAIN BARRIER AND TARGETS APOPTOSIS OF NEURODEGENERATIVE BRAIN DISEASE SITE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/469729
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8119
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13469729
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/469729 | Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereof | May 10, 2012 | Issued |
Array
(
[id] => 9397010
[patent_doc_number] => 20140094415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'HIGH-AFFINITY, DIMERIC INHIBITORS OF PSD-95 AS EFFICIENT NEUROPROTECTANTS AGAINST ISCHEMIC BRAIN DAMAGE AND FOR TREATMENT OF PAIN'
[patent_app_type] => utility
[patent_app_number] => 14/116862
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 21751
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116862
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116862 | High-affinity, dimeric inhibitors of PSD-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain | May 10, 2012 | Issued |
Array
(
[id] => 8370147
[patent_doc_number] => 20120219541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'Therapeutic Compositions Comprising Monoterpenes'
[patent_app_type] => utility
[patent_app_number] => 13/468970
[patent_app_country] => US
[patent_app_date] => 2012-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12350
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13468970
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/468970 | Therapeutic Compositions Comprising Monoterpenes | May 9, 2012 | Abandoned |
Array
(
[id] => 8442395
[patent_doc_number] => 20120259012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'Treatment for Amyotrophic Lateral Sclerosis'
[patent_app_type] => utility
[patent_app_number] => 13/465740
[patent_app_country] => US
[patent_app_date] => 2012-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10873
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13465740
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/465740 | Treatment for Amyotrophic Lateral Sclerosis | May 6, 2012 | Abandoned |
Array
(
[id] => 9537159
[patent_doc_number] => 20140161807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'METHODS OF PROMOTING CNS NEURONAL REPAIR BY INHIBITING LRP-1'
[patent_app_type] => utility
[patent_app_number] => 14/113626
[patent_app_country] => US
[patent_app_date] => 2012-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23621
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113626
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/113626 | Methods of promoting CNS neuronal repair by inhibiting LRP-1 | Apr 25, 2012 | Issued |
Array
(
[id] => 9561178
[patent_doc_number] => 20140178892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'SCREENING METHODS BASED ON VESICLE MOBILITY'
[patent_app_type] => utility
[patent_app_number] => 14/131941
[patent_app_country] => US
[patent_app_date] => 2012-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5575
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14131941
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/131941 | SCREENING METHODS BASED ON VESICLE MOBILITY | Apr 23, 2012 | Abandoned |
Array
(
[id] => 9596683
[patent_doc_number] => 20140193364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'TAM RECEPTOR LIGANDS, METABOLITES AND PRECURSORS THEREOF IN THE DETECTION AND MODULATION OF INFLAMMATORY NEUROPATHOLOGICAL DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/110685
[patent_app_country] => US
[patent_app_date] => 2012-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12228
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110685
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/110685 | TAM RECEPTOR LIGANDS, METABOLITES AND PRECURSORS THEREOF IN THE DETECTION AND MODULATION OF INFLAMMATORY NEUROPATHOLOGICAL DISEASE | Apr 3, 2012 | Abandoned |
Array
(
[id] => 8441934
[patent_doc_number] => 20120258550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'REGULATION OF AUTOPHAGY PATHWAY PHOSPHORYLATION AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/438770
[patent_app_country] => US
[patent_app_date] => 2012-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 36918
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13438770
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/438770 | REGULATION OF AUTOPHAGY PATHWAY PHOSPHORYLATION AND USES THEREOF | Apr 2, 2012 | Abandoned |
Array
(
[id] => 8951410
[patent_doc_number] => 20130197192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'Method and Composition for Crystallizing G Protein-Coupled Receptors'
[patent_app_type] => utility
[patent_app_number] => 13/436709
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 14811
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13436709
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/436709 | Method and composition for crystallizing G protein-coupled receptors | Mar 29, 2012 | Issued |
Array
(
[id] => 8301421
[patent_doc_number] => 20120183975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'Taste Receptors Of The T1R Family From Domestic Dog'
[patent_app_type] => utility
[patent_app_number] => 13/432816
[patent_app_country] => US
[patent_app_date] => 2012-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 25148
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13432816
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/432816 | Taste receptors of the T1R family from domestic dog | Mar 27, 2012 | Issued |
Array
(
[id] => 12364224
[patent_doc_number] => 09956268
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Neuropeptide Y treatment of autoimmune disease
[patent_app_type] => utility
[patent_app_number] => 13/431154
[patent_app_country] => US
[patent_app_date] => 2012-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 7880
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13431154
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/431154 | Neuropeptide Y treatment of autoimmune disease | Mar 26, 2012 | Issued |
Array
(
[id] => 9441076
[patent_doc_number] => 08710186
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-29
[patent_title] => 'Taste receptors of the T1R family from domestic cat'
[patent_app_type] => utility
[patent_app_number] => 13/430273
[patent_app_country] => US
[patent_app_date] => 2012-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 26
[patent_no_of_words] => 28612
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13430273
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/430273 | Taste receptors of the T1R family from domestic cat | Mar 25, 2012 | Issued |
Array
(
[id] => 9971159
[patent_doc_number] => 09018169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-28
[patent_title] => 'Peptides for suppressing inflammation'
[patent_app_type] => utility
[patent_app_number] => 13/981238
[patent_app_country] => US
[patent_app_date] => 2012-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13428
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13981238
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/981238 | Peptides for suppressing inflammation | Mar 15, 2012 | Issued |
Array
(
[id] => 8638257
[patent_doc_number] => 20130030059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'T1R HETERO-OLIGOMERIC TASTE RECEPTORS, CELL LINES THAT EXPRESS SAID RECEPTORS, AND TASTE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/417660
[patent_app_country] => US
[patent_app_date] => 2012-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 41620
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13417660
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/417660 | T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds | Mar 11, 2012 | Issued |
Array
(
[id] => 8266080
[patent_doc_number] => 20120165506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'NOVEL MEMBERS OF THE CAPSAICIN/VANILLOID RECEPTOR FAMILY OF PROTEINS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/417411
[patent_app_country] => US
[patent_app_date] => 2012-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 39887
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13417411
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/417411 | NOVEL MEMBERS OF THE CAPSAICIN/VANILLOID RECEPTOR FAMILY OF PROTEINS AND USES THEREOF | Mar 11, 2012 | Abandoned |
Array
(
[id] => 9262150
[patent_doc_number] => 20130344079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING PHENYLKETONURIA (PKU)'
[patent_app_type] => utility
[patent_app_number] => 14/003803
[patent_app_country] => US
[patent_app_date] => 2012-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17798
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14003803
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/003803 | Compositions and methods for diagnosing and treating phenylketonuria (PKU) | Mar 7, 2012 | Issued |
Array
(
[id] => 8381448
[patent_doc_number] => 20120225070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 13/414698
[patent_app_country] => US
[patent_app_date] => 2012-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 44541
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13414698
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/414698 | METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS | Mar 6, 2012 | Abandoned |